These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35192963)

  • 1. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
    Álvarez-López P; Campos-Varela I; Quiroga S; Díez I; Charco R; Simón-Talero M; Castells L
    Ann Hepatol; 2022; 27(3):100687. PubMed ID: 35192963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endovascular therapy accompanied by spontaneous portosystemic shunts for overt hepatic encephalopathy].
    Zhao T; Huang JY; Liu CH; Chen RB; Fan WL; Zheng WL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):181-185. PubMed ID: 37137834
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy.
    Gurtatta RS; Gaba RC; Herren JL
    J Vasc Interv Radiol; 2024 May; 35(5):659-663. PubMed ID: 38355039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts.
    Ke Q; Wang Z; Huang X; Li L; Wu W; Qiu L; Jiao Y; Xie Y; Peng X; Liu J; Guo W
    Ann Hepatol; 2022; 27(5):100725. PubMed ID: 35623551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory hepatic encephalopathy induced by spontaneous portosystemic shunt: Selective splenic vein embolization versus shunt embolization.
    Zhang L; Wei B; Wang Z; Tong H; Wu H
    Dig Liver Dis; 2023 Mar; 55(3):381-386. PubMed ID: 36175324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
    Philips CA; Kumar L; Augustine P
    Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
    Lynn AM; Singh S; Congly SE; Khemani D; Johnson DH; Wiesner RH; Kamath PS; Andrews JC; Leise MD
    Liver Transpl; 2016 Jun; 22(6):723-31. PubMed ID: 26970243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
    Laleman W; Praktiknjo M; Lauridsen MM; Bonne L; Vanderschueren E; Verslype C; Krag A; Trebicka J; Maleux G
    Metab Brain Dis; 2023 Jun; 38(5):1717-1728. PubMed ID: 36401681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance.
    Kothari R; Khanna D; Kar P
    Indian J Gastroenterol; 2023 Oct; 42(5):677-685. PubMed ID: 37642937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
    Cura M
    Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent severe hepatic encephalopathy in patients with large porto-collaterals shunts or transjugular portosystemic shunt.
    Temmerman F; Laleman W; Maleux G; Nevens F
    Acta Gastroenterol Belg; 2020; 83(1):67-71. PubMed ID: 32233274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy.
    An J; Kim KW; Han S; Lee J; Lim YS
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1418-26. PubMed ID: 24754260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.